Friday, August 14, 2015

Pre-market action JCP WX ONTX

Moving premarket with a move greater than 5%

JCP +6% J. C. Penney Company, Inc. (the "Company") issued an earnings press release on August 14, 2015 announcing its 2015 second quarter results of operations and financial condition.

WX +6.5% SHANGHAI , Aug.14, 2015 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc.("WuXi" or the "Company") (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical device industries with operations in China and the United States , today announced that it has entered into a definitive Agreement and Plan of Merger (the "Merger Agreement") with New WuXi Life Science Limited ("Parent") and WuXi Merger Limited ("Merger Sub"), a wholly owned subsidiary of Parent.

ONTX +56% (Caution, penny stock) Continuation of yesterdays move. EWTOWN, Pa. , Aug. 13, 2015 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, today announced the submission of an investigational new drug (IND) application to the U.S. Food and Drug Administration (FDA) for IV rigosertib as a treatment for higher-risk myelodysplastic syndromes (HR-MDS) after failure of hypomethylating agent (HMA) therapy. Upon clearance, the IND enables Onconova to initiate a randomized, controlled pivotal Phase 3 trial in patients with HR-MDS that have failed prior HMA therapy.



Submitted August 14, 2015 at 09:04AM by StockJock-e http://ift.tt/1N7zMFY

No comments:

Post a Comment